98
Views
4
CrossRef citations to date
0
Altmetric
Review

Cost–effectiveness of tumor necrosis factor-α antagonists in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis

, , &
Pages 155-169 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Dafna D Gladman & Ruth E Brown. (2008) Pharmacoeconomics of adalimumab for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and Crohn’s disease. Expert Review of Pharmacoeconomics & Outcomes Research 8:2, pages 111-125.
Read now

Articles from other publishers (3)

M. Frank & T. Mittendorf. (2012) Gesundheitsökonomische Aspekte einer stratifizierten Medizin in der rheumatoiden ArthritisHealth economic aspects of a stratified medicine for rheumatoid arthritis. Zeitschrift für Rheumatologie 72:1, pages 12-19.
Crossref
Nicole F. Velez, Erin X. Wei-Passanese, M. Elaine Husni, Elinor A. Mody & Abrar A. Qureshi. (2011) Management of psoriasis and psoriatic arthritis in a combined dermatology and rheumatology clinic. Archives of Dermatological Research 304:1, pages 7-13.
Crossref
Hilal Maradit Kremers, Sherine E. Gabriel & Michael F. Drummond. 2011. Rheumatology. Rheumatology 23 28.e5 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.